The FDA’s NDA017406 record pertains to the product DICOPAC KIT, marketed by GE Healthcare. The product’s marketing status is listed as discontinued.
Active ingredients in DICOPAC KIT include CYANOCOBALAMIN, CYANOCOBALAMIN CO-57, and CYANOCOBALAMIN CO-58. The product is not a reference drug and does not have a reference standard. Product details such as route and dosage form are not applicable, and the product number is 001.
Submission history for this NDA includes:
- Original submission (Type 5 – New Formulation or New Manufacturer) submitted on 1974-06-10, status AP.
- Manufacturing (CMC) submission on 1976-10-13, status AP.
- Labeling submission on 1978-05-30, status AP.
- Manufacturing (CMC) submission on 1991-01-16, status AP.
- Labeling submission on 1994-08-05, status AP.
- Additional labeling submission on 1994-08-05, status AP.
All submissions were reviewed with standard priority.
The record provides a concise view of the product’s regulatory timeline and composition.
Regulatorische Updates3. Sept. 2026•1 Min. Lesezeit
DICOPAC KIT
FDA NDA017406 for DICOPAC KIT, sponsored by GE Healthcare, indicates the product is discontinued and lists its submission history and active ingredients.
Zusammengestellt vom PharmaCountry-Team · Quelle: FDA.gov
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen